Suppression of the hypothalamic–pituitary–gonadal axis by TAK-385 (relugolix), a novel, investigational, orally active, small molecule gonadotropin-releasing hormone (GnRH) antagonist: Studies in human GnRH receptor knock-in mice

Daisuke Nakata, Tsuneo Masaki, Akira Tanaka, Mie Yoshimatsu, Y. Akinaga, Mari Asada, Reiko Sasada, Michiyasu Takeyama, Kazuhiro Miwa, Tatsuya Watanabe,

European Journal of Pharmacology · 2013 · 72 citations · 11 references

Concepts

References

11